Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 11:5:712-6.
doi: 10.1016/j.fob.2015.08.006. eCollection 2015.

Detection of circulating IgG antibodies to apolipoprotein B100 in acute myocardial infarction

Xueying Zhang  1 , Xiaohong Zhang  2 , Mingming Lei  2 , Yingzi Lin  2 , Ian L Megson  3 , Jun Wei  3 , Bo Yu  4 , Yuanzhe Jin  2
Affiliations

Detection of circulating IgG antibodies to apolipoprotein B100 in acute myocardial infarction

Xueying Zhang et al. FEBS Open Bio. .

Abstract

A number of studies have reported an association between increased levels of antibodies against oxidized low-density lipoprotein (oxLDL) and cardiovascular disease, but the anti-oxLDL antibody has not been confirmed to serve as an effective biomarker for prediction of acute myocardial infarction (AMI). Apolipoprotein B100 (ApoB100)-derived peptide fragments generated by proteolytic degradation and aldehyde modification are the major antigens in oxLDL, and so the present work was undertaken to detect circulating IgG for Apo-B100-derived peptide antigens. An in-house enzyme-linked immunosorbent assay (ELISA) was developed with eight ApoB100-derived peptide antigens (Ag1-Ag8) to detect circulating anti-ApoB100 IgG levels in 267 patients with AMI and 201 control subjects. Binary logistic regression analysis revealed that circulating IgG for Ag1 was significantly higher in the patient group than the control group (P < 0.001) after adjustment for age, gender, smoking, hypertension, diabetes and circulating levels of cholesterol, HDL, LDL, ApoA and ApoB100. None of the other seven antigens detected an increase in IgG levels in AMI patients compared with control subjects. Spearman correlation analysis showed no correlation between IgG antibody for Ag1 and clinical characteristics. In conclusion, the linear peptide antigens derived from ApoB100 may be suitable for the development of an ELISA antibody test for prediction of AMI, although further confirmation is still needed in large-scale clinical studies.

Keywords: AMI, acute myocardial infarction; Acute myocardial infarction; Antibody; ApoB100; ApoB100, apolipoprotein B100; Atherosclerosis; ELISA, enzyme-linked immunosorbent assay; HLA, human leukocyte antigen; IgG, immunoglobulin G; LDL, low-density lipoprotein; cAg, control antigen; hAgs, human antigens; oxLDL; oxLDL, oxidized low-density lipoprotein.

PubMed Disclaimer

References

    1. Andican G., Seven A., Uncu M., Cantasdemir M., Numan F., Burcak G. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease. Scand. J. Clin. Lab. Invest. 2008;68:473–478. - PubMed
    1. Che J., Li G., Wang W., Li Q., Liu H., Chen K., Liu T. Serum autoantibodies against human oxidized low-density lipoproteins are inversely associated with severity of coronary stenotic lesions calculated by gensini score. Cardiol. J. 2011;18:364–370. - PubMed
    1. Ehara S., Ueda M., Naruko T., Haze K., Itoh A., Otsuka M., Komatsu R., Matsuo T., Itabe H., Takano T., Tsukamoto Y., Yoshiyama M., Takeuchi K., Yoshikawa J., Becker A.E. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation. 2001;103:1955–1960. - PubMed
    1. Engelbertsen D., Anand D.V., Fredrikson G.N., Hopkins D., Corder R., Shah P.K., Lahiri A., Nilsson J., Bengtsson E. High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes. J. Intern. Med. 2012;271:82–89. - PubMed
    1. Fredrikson G.N., Anand D.V., Hopkins D., Corder R., Alm R., Bengtsson E., Shah P.K., Lahiri A., Nilsson J. Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes. Diabetologia. 2009;52:1426–1433. - PMC - PubMed